Amicus Therapeutics Inc FOLD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/23/24 EDT
9.32quote price arrow down-0.15 (-1.58%)
Volume
90,982
Close
9.47UNCH (UNCH)
Volume
2,693,545
52 week range
9.02 - 14.57
Loading...
  • Open9.73
  • Day High9.73
  • Day Low9.38
  • Prev Close9.72
  • 52 Week High14.57
  • 52 Week High Date12/28/23
  • 52 Week Low9.02
  • 52 Week Low Date05/13/24

Key Stats

  • Market Cap2.805B
  • Shares Out296.20M
  • 10 Day Average Volume3.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-33.26

KEY STATS

  • Open9.73
  • Day High9.73
  • Day Low9.38
  • Prev Close9.72
  • 52 Week High14.57
  • 52 Week High Date12/28/23
  • 52 Week Low9.02
  • 52 Week Low Date05/13/24
  • Market Cap2.805B
  • Shares Out296.20M
  • 10 Day Average Volume3.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-33.26

RATIOS/PROFITABILITY

  • EPS (TTM)-0.49
  • P/E (TTM)-19.21
  • Fwd P/E (NTM)-75.16
  • EBITDA (TTM)-51.347M
  • ROE (TTM)-126.10%
  • Revenue (TTM)423.489M
  • Gross Margin (TTM)89.62%
  • Net Margin (TTM)-34.73%
  • Debt To Equity (MRQ)297.18%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amicus Therapeutics Inc

 

Profile

MORE
Amicus Therapeutics, Inc. is a biotechnology company, which is focused on discovering, developing, and delivering novel medicines for rare diseases. Its two marketed therapies are Galafold, the first oral monotherapy for people living with Fabry disease who have amenable genetic variants, and Pombiliti + Opfolda, a novel treatment designed to improve uptake of active enzyme into key disease relevant tissues for adults living with late-onset Pompe disease. As an orally...
Michael Raab
Independent Chairman of the Board
Bradley Campbell
President & Chief Operating Officer
Simon Harford
Chief Financial Officer
Samantha Prout CPA
Chief Accounting Officer, Controller
Address
3675 Market Street
Philadelphia, PA
19104
United States

Top Peers

SYMBOLLASTCHG%CHG
DNLI
Denali Therapeutics Inc
19.26UNCHUNCH
RARE
Ultragenyx Pharmaceutical Inc
39.90UNCHUNCH
TWST
Twist Bioscience Corp
41.36UNCHUNCH
CPRX
Catalyst Pharmaceuticals Inc
15.92UNCHUNCH
TGTX
TG Therapeutics Inc
16.98UNCHUNCH